News

Article

Bonnie Henderson, MD, announced as interim president and CEO of HelpMeSee

(Image credit: HelpMeSee)

(Image credit: HelpMeSee)

HelpMeSee, a global nonprofit providing cataract treatment training using a simulation-based system, announced their new interim president and CEO, Bonnie Henderson, MD.

As a past president of the American Society of Cataract Refractive Surgery and a clinical professor at Tufts University School of Medicine, Henderson is an internationally recognized expert in cataract and refractive surgery.

"Dr. Henderson brings a wealth of experience in cataract surgery and simulation-based training, along with a proven track record of innovation and strategic leadership," said Jim Ueltschi, founder and chairman of the board of directors. "We are thrilled to have her step into this role and confident that our mission will reach new heights under her leadership as we work to restore sight for millions of poor people who suffer from blindness and visual impairment because they cannot get access to care."

Henderson is currently the associate editor of the Journal of Refractive Surgery and on the editorial board of Ophthalmology. She has authored more than 175 articles, papers, book chapters and abstracts, and delivered more than 300 invited lectures worldwide, including 32 invited visiting professorships and 16 named lectures.1 Henderson also created EnVision Summit, which is an international ophthalmology meeting to support and empower women leaders in medicine.

She has published 5 textbooks, with “Essentials of Cataract Surgery” being one of the most used textbooks for teaching cataract surgery in the US. She has also invented and commercialized several medical instruments including astigmatism-correcting markers, a capsule polisher, and the modified capsule tension ring. All royalties from her textbooks and instruments are donated to charity.

Henderson completed her ophthalmology residency at Harvard Medical School and Massachusetts Eye and Ear Infirmary after graduating with high honors from Dartmouth College and Dartmouth Medical School.

References:
1. HelpMeSee. Helpmesee announces dr. Bonnie Henderson as interim president and CEO. PR Newswire: news distribution, targeting and monitoring. August 15, 2023. Accessed August 15, 2023. https://www.prnewswire.com/in/news-releases/helpmesee-announces-dr-bonnie-henderson-as-interim-president-and-ceo-301900414.html?tc=eml_cleartime

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.